Genotyping Assay Market - Global Forecast 2026-2032

The genotyping assay market is undergoing dynamic transformation as advances in technology, evolving end-user demands, and global supply-chain shifts converge to reshape strategic priorities for senior decision-makers. As organizations seek to maintain a competitive edge, they must navigate rapid innovation, regulatory developments, and operational complexity with precision and foresight.

Market Snapshot: Genotyping Assay Market Growth and Outlook

The Genotyping Assay Market grew from USD 23.51 billion in 2025 to USD 26.69 billion in 2026. It is expected to continue expanding at a CAGR of 14.87%, reaching USD 62.07 billion by 2032. This expansion is being fueled by accelerating clinical adoption, advances in sequencing and PCR technologies, and increased demand for scalable, validated laboratory solutions across diverse industries.

Scope & Segmentation Overview

This market intelligence report delivers a comprehensive analysis of the full value chain, structured around key segments:

Product Types: Instruments, reagents and kits, and associated services, each with differing innovation cycles, performance profiles, and service expectations.
Technology Modalities: Microarrays, next generation sequencing (NGS), real-time PCR, and digital PCR, all supporting diverse diagnostic and research applications.
Applications: Clinical diagnostics, agricultural biotechnology, drug discovery and development, forensic science, and fundamental research, each with bespoke validation, throughput, and compliance requirements.
End Users: Academic institutions, research organizations, forensic laboratories, diagnostic centers, and biotechnology or pharmaceutical firms, all demanding solutions tailored to their operational risk and compliance standards.
Workflow Phases: Sample preparation, amplification and detection, and data analysis—segments that highlight user-driven priorities for interoperability and validated protocols.
Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting unique patterns of adoption, regulatory expectations, and partnership models.

Key Takeaways for Decision-Makers

Rapid technological convergence is driving the integration of sequencing, PCR, and bioinformatics, enabling laboratories to streamline workflows and reduce manual intervention.
User demand for modular, interoperable solutions is increasing, as organizations seek to minimize supply-chain risks and ensure adaptability to changing regulatory landscapes.
Validated, end-to-end workflows that combine sample preparation, amplification, detection, and analytics improve both laboratory efficiency and traceability, supporting clinical and forensic reliability.
Decentralization trends are encouraging the development of compact platforms and simplified processes, accelerating adoption in point-of-care and distributed lab settings.
Strategic alliances and collaborations between instrument, reagent, and software providers are crucial for delivering comprehensive, fit-for-purpose solutions.
Ongoing regulatory evolution necessitates a proactive approach to validation and documentation, especially as companion diagnostics and clinically oriented assays gain prominence.

Tariff Impact on Supply Chains and Procurement Strategies

Tariff measures introduced in 2025 have added new complexities to sourcing and pricing throughout the genotyping assay ecosystem. Stakeholders are responding by widening supplier bases, shifting manufacturing strategies, and adjusting contract terms to ensure cost transparency and procurement agility. Heightened attention is being paid to the compatibility and modularity of goods in order to future-proof laboratory operations against further policy shifts. These external pressures are reinforcing the significance of regional distribution, diversified supply chains, and lifecycle-based purchasing decisions.

Methodology & Data Sources

This analysis is grounded in a rigorous mixed-methods approach, combining structured interviews with laboratory leads, procurement experts, and regulatory specialists. Findings are corroborated by secondary research, including peer-reviewed publications, technical specifications, and official policy guidance. The research emphasizes both qualitative insight and validated quantitative evidence to deliver practical, context-aware guidance.

Why This Report Matters for Strategic Leadership

Offers senior executives actionable frameworks to guide technology investments, supply-chain decisions, and partnership strategies within the genotyping assay market.
Equips product leaders and investors with segment-specific intelligence that supports risk-managed commercialization and regulatory compliance.
Delivers tailored recommendations to help organizations accelerate clinical adoption, strengthen operational resilience, and remain adaptive to evolving compliance requirements.

Conclusion

Strategic alignment with user-driven demands, regulatory standards, and robust partnership models is central to success in the fast-evolving genotyping assay market. Informed, evidence-based planning will position organizations to seize emerging opportunities while mitigating operational risks.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Genotyping Assay Market, by Product Type

8.1. Instruments
8.2. Reagents & Kits
8.3. Services

9. Genotyping Assay Market, by Technology

9.1. Microarray
9.2. Next Generation Sequencing
9.3. PCR
9.3.1. Digital PCR
9.3.2. Real Time PCR

10. Genotyping Assay Market, by Application

10.1. Agricultural Biotechnology
10.2. Clinical Diagnostics
10.3. Drug Discovery & Development
10.4. Forensic
10.5. Research

11. Genotyping Assay Market, by End User

11.1. Academic & Research Institutes
11.2. Forensic Laboratories
11.3. Hospitals & Diagnostic Laboratories
11.4. Pharmaceutical & Biotechnology Companies

12. Genotyping Assay Market, by Workflow

12.1. Amplification & Detection
12.2. Data Analysis
12.3. Sample Preparation

13. Genotyping Assay Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Genotyping Assay Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Genotyping Assay Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Genotyping Assay Market
17. China Genotyping Assay Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 3CR Bioscience Ltd.
18.6. Azenta Life Sciences
18.7. Bio-Rad Laboratories, Inc.
18.8. Chemagen Technologie GmbH
18.9. Danaher Corporation
18.10. Eurofins Scientific SE
18.11. Grifols, S.A.
18.12. Hoffmann-La Roche Ltd.
18.13. Illumina, Inc.
18.14. LGC Biosearch Technologies
18.15. Mayo Clinic Laboratories
18.16. NeoGenomics Laboratories, Inc.
18.17. New England Biolabs, Inc.
18.18. Novogene Co., Ltd.
18.19. Oxford Nanopore Technologies PLC.
18.20. Pacific Biosciences of California, Inc.
18.21. Paragon Genomics, Inc.
18.22. Promega Corporation
18.23. QIAGEN GmbH
18.24. Standard BioTools Inc.
18.25. TAKARA BIO INC.
18.26. Tecan Trading AG
18.27. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AMPLIFICATION & DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AMPLIFICATION & DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AMPLIFICATION & DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 97. EUROPE GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 101. EUROPE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 111. AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. AFRICA GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AFRICA GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 115. AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AFRICA GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AFRICA GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. ASEAN GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASEAN GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. ASEAN GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 130. ASEAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. ASEAN GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. ASEAN GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 133. GCC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GCC GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. GCC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. GCC GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 137. GCC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. GCC GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. GCC GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 147. BRICS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. BRICS GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. BRICS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. BRICS GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 151. BRICS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. BRICS GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 154. G7 GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. G7 GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. G7 GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. G7 GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 158. G7 GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. G7 GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. G7 GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 161. NATO GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. NATO GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. NATO GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 165. NATO GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. NATO GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. NATO GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 176. CHINA GENOTYPING ASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. CHINA GENOTYPING ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. CHINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. CHINA GENOTYPING ASSAY MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 180. CHINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. CHINA GENOTYPING ASSAY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. CHINA GENOTYPING ASSAY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Genotyping Assay market report include:

3CR Bioscience Ltd.
Azenta Life Sciences
Bio-Rad Laboratories, Inc.
Chemagen Technologie GmbH
Danaher Corporation
Eurofins Scientific SE
Grifols, S.A.
Hoffmann-La Roche Ltd.
Illumina, Inc.
LGC Biosearch Technologies
Mayo Clinic Laboratories
NeoGenomics Laboratories, Inc.
New England Biolabs, Inc.
Novogene Co., Ltd.
Oxford Nanopore Technologies PLC.
Pacific Biosciences of California, Inc.
Paragon Genomics, Inc.
Promega Corporation
QIAGEN GmbH
Standard BioTools Inc.
TAKARA BIO INC.
Tecan Trading AG
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 26.69 Billion
Forecasted Market Value ( USD ) by 2032	$ 62.07 Billion
Compound Annual Growth Rate	14.8%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Genotyping Assay Market Growth and Outlook

Scope & Segmentation Overview

Key Takeaways for Decision-Makers

Tariff Impact on Supply Chains and Procurement Strategies

Methodology & Data Sources

Why This Report Matters for Strategic Leadership

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Genotyping Assay Market Report 2025

Genotyping Market - Global Forecast 2025-2032

Human MTHFR Genotyping Detection Kits Market - Global Forecast 2025-2030

Single Nucleotide Polymorphism Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Antimicrobial Resistance (AMR) Genotyping Panels Global Market Report 2025